TSX:LOVEPersonal Products
Cannara Biotech (TSX:LOVE) Margin Improvement To 10.5% Reinforces Bullish Community Narratives
Cannara Biotech (TSX:LOVE) has just posted its latest figures with Q1 2026 revenue at $30.1 million and basic EPS of $0.011. This is set against a trailing twelve month EPS of $0.129 on revenue of $112.2 million and net income of $11.8 million. Over the past year, revenue has moved from $23.2 million in Q4 2024 to $30.1 million in Q1 2026. Quarterly basic EPS has ranged from $0.025 in Q1 2025 to $0.045 in Q3 2025, giving investors a clear view of how earnings have translated into margins over...